JZ3-18997-56526
3 vaccinations
2 coded responses
40 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 605 / IL
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Moderna
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
-
2021-01-22
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling — Feeling: GoodFree text: I developed a 8cmx10cm swollen, red, itchy rash over my injection site. Required halobetasol ointment to tolerate the itching. Lasted about 2 days with minimal residual itching for about 2 days afterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-02-05
-
2021-02-06
Dose 2 — Moderna
-
2021-02-06
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, VomitingAdult check-in
- 2021-02-08
- 2021-02-09
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-02-12
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-05-08
- 2021-08-07
-
2021-11-18
Dose 3 — Moderna
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-12-02
-
2021-12-09
Survey response — day 21, dose 3MedDRA: Cholestasis, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cholestasis of pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-12-16
- 2021-12-23
- 2021-12-30
- 2022-02-17
- 2022-05-19
- 2022-11-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-06 | Moderna | |
| 3 | 2021-11-18 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 2 — day 14, dose 1
Symptoms: I developed a 8cmx10cm swollen, red, itchy rash over my injection site. Required halobetasol ointment to tolerate the itching. Lasted about 2 days with minimal residual itching for about 2 days after
Release 10 — day 21, dose 3
Symptoms: Cholestasis of pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholestasis | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release